Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 2014. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) under the GlaxoSmithKline US Deferred Performance Share Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document is limited to a specific insider transaction notification and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only reported change is an increase in the American Depositary Shares (ADSs) held by Mr. D E Troy.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. It strictly details a transaction where Mr. D E Troy acquired 379.844 ADSs at a price of $45.63 per ADS following the re-investment of a dividend paid on October 2, 2014.
Investor Verification Points
- Verify the total number of ADSs held by Mr. D E Troy post-transaction.
- Confirm the dividend reinvestment terms of the GlaxoSmithKline US Deferred Performance Share Plan.
- Check the market price of GSK ADSs on October 14, 2014, to validate the transaction price of $45.63.